DNA microarray and cancer

Current Opinion in Oncology

Volumn 15, Issue 1, 2003, Pages 36-43

  Guo, Qingbin M ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GENETICS; CANCER GROWTH; CANCER RISK; CARCINOGENESIS; DIAGNOSTIC ACCURACY; DNA MICROARRAY; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC DISORDER; HUMAN; HUMAN GENOME; MEDICAL RESEARCH; ONCOGENE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW;

FORECASTING; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; HUMANS; NEOPLASM PROTEINS; NEOPLASMS; NUCLEIC ACID HYBRIDIZATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 0037246315     PISSN: 10408746     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001622-200301000-00005     Document Type: Review

References (96)

1. Schulze A, Downward J: Navigating gene expression using microarrays: a technology review. Nat Cell Biol 2001, 3:E190-E195.
2. Clarke PA, te Poele R, Wooster R, et al.: Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem Pharmacol 2001, 62:1311-1336.
3. Mei R, Galipeau PC, Prass C, et al.: Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays. Genome Res 2000, 10:1126-1137.
4. Schubert EL, Hsu L, Cousens LA, et al.: Single nucleotide polymorphism array analysis of flow-sorted epithelial cells from frozen versus fixed tissues for whole genome analysis of allelic loss in breast cancer. Am J Pathol 2002, 160:73-79.
5. Primdahl H, Wikman FP, von der Maase H, et al.: Allelic imbalances in human bladder cancer: genome-wide detection with high-density single-nucleotide polymorphism arrays. J Natl Cancer Inst 2002, 94:216-223.
6. Lu ML, Wikman F, Orntoft TF, et al,: Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods. Clin Cancer Res 2002, 8:171-179.
7. Hacia JG, Woski SA, Fidanza J, et al.: Enhanced high density oligonucleotide array-based sequence analysis using modified nucleoside triphosphates. Nucleic Acids Res 1998, 26:4975-4982.
8. Kim IJ, Kang HC, Park JH, et al.: RET oligonucleotide microarray for the detection of RET mutations in multiple endocrine neoplasia type 2 syndromes. Clin Cancer Res 2002, 8:457-463
9. Hermsen MA, Weiss MM, Meijer GA, et al.: Detection of chromosomal abnormalities by comparative genomic hybridization. Methods Mol Biol 2001, 175:47-55.
10. Hodgson G, Hager JH, Volik S, et al.: Genome scanning with array CGH delineates regional alterations in mouse islet carcinomas. Nat Genet 2001, 29:459-464. • In an effort to identify chromosomal regions altered in mouse islet carcinomas, array CGH made from genomic bacterial artificial chromosome (BAC) clones (2-20 Mb) was used to investigate transgenic mice that express SV40 T-antigens in the pancreatic islets.
11. Wilhelm M, Veltman JA, Olshen AB, et al.: Array-based comparative genomic hybridization for the differential diagnosis of renal cell cancer. Cancer Res 2002, 62:957-960.
12. Cai WW, Mao JH, Chow CW, et al.: Genome-wide detection of chromosomal imbalances in tumors using BAC microarrays. Nat Biotechnol 2002, 20:393-396. • This technical study aimed to improve array CGH quality by fabricating more superior microarrays using genomic bacterial artificial chromosome (BAC) clones.
13. Pollack JR, Perou CM, Alizadeh AA, et al.: Genome-wide analysis of DNA copy-number changes using cDNA microarrays. Nat Genet 1999, 23:41-46.
14. Jackson-Grusby L, Beard C, Possemato R, et al.: Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation. Nat Genet 2001, 27:31-39.
15. Suzuki H, Gabrielson E, Chen W, et al.: A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat Genet 2002, 31:141-149.
16. Liang G, Gonzales FA, Jones PA, et al.: Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res 2002, 62:961-966.
17. Gitan RS, Shi H, Chen CM, et al.: Methylation-specific oligonucleotide microarray: a new potential for high-throughput methylation analysis. Genome Res 2002, 12:158-164.
18. Shi H, Yan PS, Chen CM, et al.: Expressed CpG island sequence tag microarray for dual screening of DNA hypermethylation and gene silencing in cancer cells. Cancer Res 2002, 62:3214-3220. •• The differential methylation hybridization technique using the CpG island microarray was developed previously by this group to identify altered DNA methylations in the cell. This study further improved the technique to identify changes in both methylation and gene expression. This refined technique provides a more effective method to distinguish direct targets from indirect targets of DNA demethylation.
19. Dhanasekaran SM, Barrette TR, Ghosh D, et al.: Delineation of prognostic biomarkers in prostate cancer. Nature 2001, 412:822-826. •• Gene expression profiling of more than 50 normal and tumor prostate specimens using cDNA microarray generated molecular signatures for various types of prostate cancers. Two of the markers identified (hepsin and pim-1) were further characterized using tissue microarrays and found to be correlated with the clinical outcome.
20. Hippo Y, Taniguchi H, Tsutsumi S, et al.: Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 2002, 62:233-240.
21. Hedenfak IA, Ringner M, Trent JM, et al.: Gene expression in inherited breast cancer. Adv Cancer Res 2002, 84:1-34.
22. Chen X, Cheung ST, So S, et al.: Gene expression patterns in human liver cancers. Mol Biol Cell 2002, 13:1929-1939.
23. Han H, Bearss DJ, Browne LW, et al.; Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res 2002, 62:2890-2896.
24. Tonin PN, Hudson TJ, Rodier F, et al.: Microarray analysis of gene expression mirrors the biology of an ovarian cancer model. Oncogene 2001, 20:6617-6626.
25. Luo J, Dunn T, Ewing C, et al.: Gene expression signature of benign prostatic hyperplasia revealed by cDNA microarray analysis. Prostate 2002, 51:189-200.
26. Al Moustafa AE, Alaoui-Jamali MA, Batist G, et al.: Identification of genes associated with head and neck carcinogenesis by cDNA microarray comparison between matched primary normal epithelial and squamous carcinoma cells. Oncogene 2002, 21:2634-2640.
27. Belbin TJ, Singh B, Barber I, et al.: Molecular classification of head and neck squamous cell carcinoma using cDNA microarrays. Cancer Res 2002, 62:1184-1190.
28. Bhattacharjee A, Richards WG, Staunton J, et al.: Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses. Proc Natl Acad Sci U S A 2001, 98:13790-13795. • Using an oligonucleotide microarray of 12,600 genes, the authors profiled gene expressions of 186 lung tumor samples and clustered them into distinctive subclasses.
29. Garber ME, Troyanskaya OG, Schluens K, et al.: Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A 2001, 98:13784-13789. • Using a 24,000-element cDNA microarray, gene expressions of 67 human lung tumors were profiled and clustered into subgroups.
30. Golub TR, Slonim DK, Tamayo P, et al.: Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science 1999, 286:531-537.
31. Alizadeh AA, Eisen MB, Davis RE, et al.: Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
32. Unger MA, Rishi M, Clemmer VB, et al.: Characterization of adjacent breast tumors using oligonucleotide microarrays. Breast Cancer Res 2001, 3:336-341.
33. Ramaswamy S, Tamayo P, Rifkin R, et al.: Multiclass cancer diagnosis using tumor gene expression signatures. Proc Natl Acad Sci U S A 2001, 98:15149-15154. •• In an effort to test the feasibility of multiclass cancer diagnosis by DNA microarray, the authors profiled gene expressions of a large number of different kinds of tumor samples and classified them using both unsupervised and supervised learning methods. They found that classification accuracy of 78% by gene expression profiling is far better than the accuracy of random classification (9%).
34. Su Al, Welsh JB, Sapinoso LM, et al.: Molecular classification of human carcinomas by use of gene expression signatures. Cancer Res 2001, 61:7388-7393. •• In this study, the genes were filtered and ranked for their contribution to tumor distinction. These genes and supervised machine learning algorithms then were used to classify multiple types of tumors.
35. Ohmine K, Ota J, Ueda M, et al.: Characterization of stage progression in chronic myeloid leukemia by DNA microarray with purified hematopoietic stem cells. Oncogene 2001, 20:8249-8257.
36. Karan D, Kelly DL, Rizzino A, et al.: Expression profile of differentially-regulated genes during progression of androgen-independent growth in human prostate cancer cells. Carcinogenesis 2002, 23:967-976.
37. Seftor EA, Meltzer PS, Kirschmann DA, et al.: Molecular determinants of human uveal melanoma invasion and metastasis. Clin Exp Metastasis 2002, 19:233-246.
38. Takahashi M, Rhodes DR, Furge KA, et al.: Gene expression profiling of clear cell renal cell carcinoma: gene identification and prognostic classification. Proc Natl Acad Sci U S A 2001, 98:9754-9759.
39. Sorlie T, Perou CM, Tibshirani R, et al.: Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.
40. Rosenwald A, Wright G, Chan WC, et al.: The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma. N Engl J Med 2002, 346:1937-1947.
41. Wigle DA, Jurisica I, Radulovich N, et al.: Molecular profiling of non-small cell lung cancer and correlation with disease-free survival. Cancer Res 2002, 62:3005-3008.
42. van 't Veer LJ Dai H, van de Vijver MJ, et al.: Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002, 415:530-536. •• Using supervised and unsupervised classification of gene expression profiles obtained from 117 primary breast tumors, the authors identified prognostic profiles that can predict clinical outcome of these patients.
43. Pomeroy SL, Tamayo P, Gaasenbeek M, et al.: Prediction of central nervous system embryonal tumor outcome based on gene expression. Nature 2002, 415:436-442. •• The authors studied the difference between medulloblastomas and other brain tumors by gene expression profiling. They demonstrated that the clinical outcome of medulloblastomas in children can be predicted by their gene expression patterns.
44. Shipp MA, Ross KN, Tamayo P, et al.: Diffuse large B-cell lymphoma outcome prediction by gene-expression profiling and supervised machine learning. Nat Med 2002, 8:68-74. •• Using an oligonucleotide microarray of 6817 genes and supervised learning techniques, the gene expression profiles of patients with diffuse large B-cell lymphoma were classified into two categories with very different survival rates.
45. Coller HA, Grandori C, Tamayo P, et al.: Expression analysis with oligonucleotide microarrays reveals that MYC regulates genes involved in growth, cell cycle, signaling, and adhesion. Proc Natl Acad Sci U S A 2000, 97:3260-3265.
46. Guo QM, Matek RL, Kim S, et al.: Identification of c-myc responsive genes using rat cDNA microarray. Cancer Res 2000, 60:5922-5928.
47. Schuhmacher M, Kohlhuber F, Holzel M, et al.: The transcriptional program of a human B cell line in response to Myc. Nucleic Acids Res 2001, 29:397-406.
48. Menssen A, Hermeking H: Characterization of the c-MYC-regulated transcriptome by SAGE: identification and analysis of c-MYC target genes. Proc Natl Acad Sci U S A 2002, 99:6274-6279. • Using serial analysis of gene expression, the authors identified 216 upregutated genes and 260 downregulated genes after adenoviral expression of c-MYC in human primary cells. Fifty-three upregulated genes were confirmed by microarray analysis and quantitative real-time polymerase chain reaction.
49. O'Hagan RC, Schreiber-Agus N, Chen K, et al.: Gene-target recognition among members of the myc superfamily and implications for oncogenesis. Nat Genet 2000, 24:113-119.
50. Stanelle J, Stiewe T, Theseling CC, et al.: Gene expression changes in response to E2F1 activation. Nucleic Acids Res 2002, 30:1859-1867.
51. Wells J, Graveel CR, Bartley SM, et al.: The identification of E2F1-specific target genes. Proc Natl Acad Sci U S A 2002, 99:3890-3895.
52. Mathai JP, Germain M, Marcellus RC, et al.: Induction and endoplasmic reticulum location of BIK/NBK in response to apoptotic signaling by E1A and p53. Oncogene 2002, 21:2534-2544.
53. Zhao R, Gish K, Murphy M, et al.: Analysis of p53-regulated gene expression patterns using oligonucleotide arrays. Genes Dev 2000, 14:981-993.
54. Aprelikova O, Pace AJ, Fang B, et al.: BRCA1 is a selective co-activator of 14-3-3 sigma gene transcription in mouse embryonic stem cells. J Biol Chem 2001, 276:25647-25650.
55. Welcsh PL, Lee MK, Gonzalez-Hernandez RM, et al.: BROA1 transcriptionally regulares genes involved in breast tumorigenesis. Proc Natl Acad Sci U S A 2002, 99:7560-7565. • This study used ah inducible BRAC1 in human epithelial cell line and an oligonucreotide microarray of 6800 genes to look for genes regulated by BROA1. In the 373 genes identified, many have been known to be associated with breast tumorigenesis.
56. Iritani BM, Eisenman RN: c-MYC enhances protein synthesis and cell size during B lymphocyte development. Proc Natl Acad Sci U S A 1999, 96:13180-13185.
57. Schuhmacher M, Staege MS, Pajic A, et al.: Control of cell growth by c-MYC in the absence of cell division. Curr Biol 1999, 9:1255-1258.
58. Barradas M, Gonos ES, Zebedee Z, et al.: Identification of a candidate tumor-suppressor gene specifically activated during Ras-induced senescence. Exp Cell Res 2002, 273:127-137.
59. Nakamoto T, Suzuki T, Huang J, et al.: Analysis of gene expression profile in p130(Cas)-deficient fibroblasts. Biochem Biophys Res Commun 2002, 294:635-641.
60. Tice DA, Szeto W, Soloviev I, et al.: Synergistic induction of tumor antigens by Wnt-1 signaling and retinoic acid revealed by gene expression profiling. J Biol Chem 2002, 277:14329-14335.
61. Stolarov J, Chang K, Reiner A, et al.: Design of a retroviral-mediated ecdysone-inducible system and its application to the expression profiling of the PTEN tumor suppressor. Proc Natl Acad Sci U S A 2001, 98:13043-13048.
62. Watanabe H, Suzuki A, Mizutani T, et al.: Genome-wide analysis of changes in early gene expression induced by oestrogen. Genes Cells 2002, 7:497-507.
63. Yuan R, Fan S, Achary M, et al.: Altered gene expression pattern in cultured human breast cancer cells treated with hepatocyte growth factor/scatter factor in the setting of DNA damage. Cancer Res 2001, 61:8022-8031.
64. Cardozo AK, Heimberg H, Heremans Y, et al.: A comprehensive analysis of cytokine-induced and nuclear factor-kappa B-dependent genes in primary rat pancreatic beta-cells. J Biol Chem 2001, 276:48879-48886.
65. Chang YE, Laimins LA: Interferon-inducible genes are major targets of human papillomavirus type 31: insights from microarray analysis. Dis Markers 2001, 17:139-142.
66. Paulose-Murphy M, Ha NK, Xiang C, et al.: Transcription program of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus). J Virol 2001, 75:4843-4853.
67. Zhang S, Day IN, Ye S: Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiol Genomics 2001, 5:187-192.
68. Li J, Lee JM, Johnson JA: Microarray analysis reveals an antioxidant responsive element-driven gene set involved in conferring protection from an oxidative stress-induced apoptosis in IMR-32 cells. J Biol Chem 2002, 277:388-394.
69. Voehringer DW, Hirschberg DL Xiao J, et al.: Gene microarray identification of redox and mitochondrial elements that control resistanoe or sensitivity to apoptosis. Proc Natl Acad Sci U S A 2000, 97:2680-2685.
70. Scandurro AB, Weldon CW, Figueroa YG, et al.: Gene microarray analysis reveals a novel hypoxia signal transduction pathway in human hepatocellular carcinoma cells. Int J Oncol 2001, 19:129-135.
71. Shelton DN, Chang E, Whittier PS, et al.: Microarray analysis of replicative senescence. Curr Biol 1999, 9:939-945.
72. Schwarze SR, DePrimo SE, Grabert LM, et al.: Novel pathways associated with bypassing cellular senescence in human prostate epithelial cells. J Biol Chem 2002, 277:14877-14883. • This study compared gene expression profiles of senescent and immortalized human prostate epithelial cells using a cDNA microarray of 20,000 genes.
73. Scherf U, Ross DT, Waltham M, et al.: A gene expression database for the molecular pharmacology of cancer. Nat Genet 2000, 24:236-244.
74. Butte AJ, Tamayo P, Slonim D, et al.: Discovering functionat relationships between RNA expression and chemotherapeutic susceptibility using relevance networks. Proc Natl Acad Sci U S A 2000, 97:12182-12186.
75. Zembutsu H, Ohnishi Y, Tsunoda T, et al.: Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res 2002, 62:518-527.
76. Dan S, Tsunoda T, Kitahara O, et al.: An integrated database of chemosensitivity to 55 anticancer drugs and gene expression profiles of 39 human cancer cell lines. Cancer Res 2002, 62:1139-1147.
77. Waring JF, Jolly RA, Ciurlionis R, et al.: Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol Appl Pharmacol 2001, 175:28-42.
78. Staunton JE, Slonim DK, Coller HA, et al.: Chemosensitivity prediction by transcriptional profiling. Proc Natl Acad Sci U S A 2001, 98:10787-10792.
79. Gerhold D, Lu M, Xu J, et al.: Monitoring expression of genes involved in drug metabolism and toxicology using DNA microarrays. Physiol Genomics 2001, 5:161-170.
80. Dimitroulakos J, Marhin WH, Tokunaga J, et al.: Microarray and biochemical analysis of lovastatin-induced apoptosis of squamous cell carcinomas. Neoplasia 2002, 4:337-346.
81. Zhou Y, Gwadry FG, Reinhold WC, et al.: Transcriptionat regulation of mitotic genes by camptothecin-induced DNA damage: microarray analysis of dose-and time-dependent effects. Cancer Res 2002, 62:1688-1695.
82. Chang BD, Swift ME, Shen M, et al.: Molecular determinants of terminal growth arrest induced in tumor cells by a chemotherapeutic agent. Proc Natl Acad Sci U S A 2002, 99:389-394.
83. Dong Y, Ganther HE, Stewart C, et al.: Identification of molecular targets associated with selenium-induced growth inhibition in human breast cells using cDNA microarrays. Cancer Res 2002, 62:708-714.
84. Iizaka M, Furukawa Y, Tsunoda T, et al.: Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun 2002, 292:498-512.
85. Yih LH, Peck K, Lee TC: Changes in gene expression profiles of human fibroblasts in response to sodium arsenite treatment. Carcinogenesis 2002, 23:867-876.
86. West M, Blanchette C, Dressman H, et al.: Predicting the clinical status of human breast cancer by using gene expression profiles. Proc Natl Acad Sci U S A 2001, 98:11462-11467.
87. Kihara C, Tsunoda T, Tanaka T, et al.: Prediction of sensitivity of esophageal tumors to adjuvant chemotherapy by cDNA microarray analysis of gene-expression profiles. Cancer Res 2001, 61:6474-6479.
88. Kitahara O, Katagiri T, Tsunoda T, et al.: Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia 2002, 4:295-303.
89. Piper MD, Daran-Lapujade P, Bro C, et al.: Reproducibility of oligonucleotide transcriptome anatyses: an interlaboratory comparison using chemostat cultures of Saccharomyces cerevisiae. J Biol Chem 2002, 277:37001-37008.
90. Lee ML, Kuo FC, Whitmore GA, et al.: Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proo Natl Acad Sci U S A 2000, 97:9834-9839.
91. Jenssen TK, Langaas M, Kuo WP, et al.: Analysis of repeatability in spotted cDNA microarrays. Nucleic Acids Res 2002, 30:3235-3244.
92. Tran PH, Peiffer DA, Shin Y, et al.: Microarray optimizations: increasing spot accuracy and automated identification of true microarray signals. Nucleic Acids Res 2002, 30:e54.
93. Wang X, Ghosh S, Guo SW: Quantitative quality control in microarray image processing and data acquisition. Nucleic Acids Res 2001, 29:E75.
94. Yuen T, Wurmbach E, Pfeffer RL, et al.: Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res 2002, 30:e48.
95. Taniguchi M, Miura K, Iwao H, et al.: Quantitative assessment of DNA microarrays-comparison with Northern blot analyses. Genomics 2001, 71:34-39.
96. Emmert-Buck MR, Bonner RF, Smith PD, et al.: Laser capture microdissection. Science 1996, 274:998-1001.